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Abstract Calpastatin, the natural inhibitor of calpain, is
present in rat brain in multiple forms, having different molecular
masses, due to the presence of one (low Mr form) or four (high
Mr form) repetitive inhibitory domains. Recombinant and native
calpastatin forms are substrates of protein kinase C, which
phosphorylates a single serine residue at their N-terminus.
Furthermore, both low and high Mr calpastatins are phospho-
rylated by protein kinase C at the same site. These calpastatin
forms are phosphorylated also by protein kinase A, although with
a lower efficiency. The incorporation of a phosphate group
determines an increase in the concentration of Ca2 required to
induce the formation of the calpain-calpastatin complex. This
effect results in a large decrease of the inhibitory efficiency of
calpastatins. We suggest that phosphorylation of calpastatin
represents a mechanism capable to balance the actual amount of
active calpastatin to the level of calpain to be activated.
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1. Introduction
A variety of natural e¡ectors are involved in the regulation
of the calcium-dependent proteolytic system through two dis-
tinct processes, the ¢rst one promoting activation of calpain
and involving interaction with phospholipids [1], nuclei and
speci¢c protein factors [2], the second one promoting inhibi-
tion by the association with the inhibitory protein calpastatin
[3]. The formation of the enzyme-inhibitor complex occurs
only in the presence of relatively high [Ca2], which induces
a conformational change that discloses the catalytic site [4].
This reversible process is followed by the removal of peptide
segments from the N-terminal region of calpain in two auto-
proteolytic steps, a process that further increases the a⁄nity
of calpastatin for the enzyme [5].
Recently, we have reported that the rat brain contains ¢ve
di¡erent transcripts for calpastatin [6], some of which encod-
ing the complete molecular structure, consisting of one N-
terminal domain and four repetitive inhibitory domains
(high Mr calpastatin). We have also identi¢ed truncated cal-
pastatin forms, one having speci¢cally the N-terminal domain
associated with only one inhibitory domain (low Mr calpasta-
tin) and another one consisting of the single and inactive N-
terminal domain.
Expression of these recombinant forms [7] has revealed that
the low Mr calpastatin is the most active form, showing an
inhibitory activity approximately three times higher than that
of the complete high Mr calpastatin form. Moreover, analysis
of the properties of the isolated N-terminal domain has indi-
cated that this region is involved in the speci¢c recognition of
calpain isozymes. The presence of multiple forms of calpasta-
tin has been con¢rmed by the isolation from rat brain homo-
genates of a very active low Mr calpastatin together with high
Mr inhibitor forms [7]. The concomitant expression of multi-
ple calpastatin forms may be relevant to regulate separately W-
calpain and m-calpain that can be present in a single cell.
We have also established that calpastatin can undergo re-
versible post-translational modi¢cations, producing changes
in its capacity of calpain recognition and obviously in the
inhibitory e⁄ciency [8]. This modulatory mechanism has
been suggested by the observation that calpastatin from
many tissue homogenates is eluted by acidic ion exchange
chromatography in two forms, both containing a mixture of
high Mr and low Mr calpastatins. Treatment with protein
kinases and phosphatases has indicated that both forms are
interconvertible products of a reversible phosphorylation-de-
phosphorylation process [9]. In rat brain, phosphorylated cal-
pastatin shows a considerably reduced inhibitory e⁄ciency
particularly against m-calpain [8], whereas in skeletal muscle,
the same post-translational modi¢cation changes the speci¢c-
ity of the inhibitor.
We now report more detailed studies concerning the phos-
phorylation of calpastatin forms, puri¢ed from rat brain.
These results indicate that phosphorylation occurs at the N-
terminus of the protein molecule and results in the modula-
tion of the a⁄nity of calpastatin for the two homologous
calpain isoforms. Identical results have been obtained with
recombinant calpastatin forms. The generation of phospho
and dephospho forms, with a di¡erent capacity to interact
with calpain, could represent a mechanism to balance calpa-
statin and calpain during activation of the system.
2. Materials and methods
2.1. Puri¢cation and assay of calpains and calpastatins
Rat brain W-calpain and m-calpain were puri¢ed and assayed as
previously described [8]. One unit of enzyme activity is de¢ned as
the amount that releases 1 Wmol/h of free K-amino groups under
the speci¢ed conditions.
Rat brain calpastatins were puri¢ed and assayed as described [8].
One unit of calpastatin activity is de¢ned as the amount required to
inhibit one unit of enzyme activity.
2.2. Expression of calpastatins as fusion proteins in Escherichia coli
Five cDNAs for calpastatin were obtained from rat brain mRNA,
ampli¢ed and ligated into the pGEX2T expression vector [6]. E. coli
TOP 10FP cells were transfected by electroporation. Expression and
puri¢cation of GST-calpastatins were carried out as previously de-
scribed [7].
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2.3. Isolation of rat brain protein kinase A (PKA) and protein kinase C
(PKC)
PKA and PKC from rat brain were assayed and puri¢ed as pre-
viously described [8]. The ¢nal PKC preparation resulted to be a
mixture of PKC isozymes, composed by 2/3 of K-PKC and 1/3 of
L-PKC. N-isozyme was present only in trace amounts. One unit of
protein kinase activity was de¢ned as the amount causing the incor-
poration of 1 nmol of 32P into histone type IIIS under the speci¢ed
conditions [8].
2.4. Phosphorylation of native and recombinant calpastatins by PKC
and PKA
Puri¢ed native or recombinant calpastatin were incubated at 30‡C
for 30 min with puri¢ed rat brain PKC in 50 mM sodium borate, pH
7.5, containing 5 mM MgCl2, 10 WM ATP, 0.4 WCi [Q32P]ATP, 10 Wg
phosphatidylserine, 0.2 Wg diacylglycerol and 0.5 mM CaCl2. Under
these conditions, the reaction is almost linear for the ¢rst 5^10 min
and substrate phosphorylation is completed in approximately 20^25
min [8]. The reaction was stopped by heating at 90‡C for 3 min, the
mixture was centrifuged at 50 000Ug for 10 min and the supernatant,
containing phosphorylated calpastatin, was collected. Phosphorylated
calpastatin was then isolated by a⁄nity chromatography on a Sephar-
ose column containing immobilized calpain under the conditions
speci¢ed below. 32P incorporation into calpastatin was measured on
an aliquot of the eluted protein by counting in a scintillation counter
and expressed as mol of 32P/mol of protein.
The phosphorylation of calpastatins by PKA was carried out in the
same conditions replacing diacylglycerol, phosphatidylserine and cal-
cium with 20 WM cAMP [9].
2.5. A⁄nity chromatography of calpastatin onto a carboxy-methylated
calpain-immobilized column
Erythrocyte calpain was puri¢ed and inactivated with iodoacet-
amide as previously described [10]. A calpain-Sepharose column was
prepared by coupling carboxy-methylated calpain (0.4 mg) with CNBr
Sepharose (Amersham Pharmacia Biotech) following the manufactur-
er’s instructions and equilibrated in 50 mM sodium borate bu¡er pH
7.5, containing 0.5 mM L-mercaptoethanol and 1 mM CaCl2. Calpa-
statin was loaded onto the column and eluted with 50mM sodium
borate bu¡er pH 7.5, containing 0.5 mM L-mercaptoethanol and
0.1 mM ethylene diamine tetraacetate (EDTA).
2.6. Identi¢cation of phosphorylated amino acid residues
Phosphorylated native or recombinant calpastatin was digested
overnight with trypsin (ratio 100:1) in 50 mM sodium borate bu¡er,
pH 8.5, containing 5% CH3CN. After digestion, the sample was
lyophilized, suspended in 50 Wl of H2O and the pH was acidi¢ed by
the addition of 0.1% tri£uoroacetic acid. The tryptic peptides were
separated by HPLC using a C-18 reverse phase chromatographic col-
umn (1U100 mm) equilibrated in distilled water containing 0.1% tri-
£uoroacetic acid. The elution of the tryptic peptides was carried out
by a linear gradient of CH3CN (from 0 to 70%). To identify the
radioactive peptides, an aliquot (0.01 ml) of each eluted fraction
was applied onto a nitrocellulose sheet which was then submitted to
autoradiography. This analysis revealed only one 32P-labelled peak.
Fractions corresponding to the labelled peak were collected, lyophi-
lized and the amino acid sequence of the labelled peptide was deter-
mined with a Beckman L3000 sequencer [11].
3. Results
3.1. Phosphorylation of native and recombinant low Mr
calpastatin
We have previously reported [6] that rat brain contains a
mRNA encoding a form of calpastatin having the N-terminal
domain and a single inhibitor repeat (low Mr form). The
recombinant protein, expressed in E. coli, showed not only
calpastatin activity against both W- and m-calpain but also a
much higher inhibitory e⁄ciency as compared to the other
recombinant calpastatin forms. A similar low Mr calpastatin
form has been isolated from rat brain tissue and possesses the
identical functional properties of that expressed in E. coli.
To determine if phosphorylation is a mechanism for the
control of calpastatin’s e⁄ciency and selectivity, we have in-
cubated the native rat brain and recombinant low Mr calpa-
statins with PKC, also puri¢ed from rat brain. As shown in
Fig. 1, both proteins incorporate 32P in an amount reaching a
ratio of 1 mol of phosphate per mol of protein. In compara-
tive analysis, PKA resulted to be less e⁄cient in promoting
calpastatin phosphorylation.
To identify the calpastatin region in which phosphorylation
occurs, the inhibitor was incubated for 30 min with PKC. In
these conditions, described in Fig. 1, the phosphorylation re-
action was completed. Phospho-calpastatin was recovered
from the incubation mixture by heating at 90‡C for 3 min
followed by a⁄nity chromatography on a Sepharose column
containing immobilized carboxy-methylated calpain (see Sec-
tion 2). The [32P]calpastatin was then collected and digested
with trypsin. The tryptic peptides were separated by HPLC
using a C18-reverse phase column and an aliquot of the eluted
material was analyzed for its radioactivity content. Only one
peptide peak was found radioactive and fractions containing
the labelled material were collected, pooled and utilized to
determine the amino acid sequence. As shown in Fig. 2, the
amino acid sequence identi¢ed in both native and recombi-
nant inhibitors corresponds to a segment present at the N-
terminus of calpastatin. Furthermore, the identi¢ed sequence
is consistent with a PKC phosphorylation site [12].
3.2. The e¡ect of phosphorylation on inhibitory properties of
low Mr calpastatins
To establish the e¡ect of phosphorylation on the inhibitory
properties of native and recombinant low Mr calpastatins,
their phosphorylated forms were analyzed for their capacity
to inhibit homologous W-calpain and m-calpain. As shown in
Fig. 3, unphosphorylated native and recombinant low Mr
calpastatins show an inhibitory activity against rat brain W-
Fig. 1. Phosphorylation of native and recombinant low Mr calpasta-
tin by PKC and PKA. Puri¢ed native (A) or recombinant (B) low
Mr calpastatin were incubated with PKC (b) or PKA (a) and
[Q-32P]ATP as described in Section 2. At the indicated times, the re-
actions were stopped by heating at 90‡C for 3 min and the mixtures
were centrifuged at 50 000Ug for 10 min. The clear supernatants
were then ¢ltered through a calpain-Sepharose column equilibrated
with 50 mM sodium borate, pH 7.5, containing 1 mM Ca2. Cal-
pastatin was retained by the resin and then eluted with the same
bu¡er containing 0.1 mM EDTA. 32P incorporation into calpastatin
was measured on an aliquot of the eluted protein by counting in a
scintillation counter and expressed as mol of 32P/mol of protein.
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calpain and m-calpain, although with a higher e⁄ciency with
respect to the former. Following phosphorylation, a signi¢-
cant decrease in the e⁄ciency of the inhibitors against both
proteinase isozymes occurs. Phosphorylated native and re-
combinant low Mr calpastatins express less than 1/2 of their
potential activity on W-calpain and are almost completely in-
active on m-calpain. These data provide additional evidence
supporting the role of the N-terminal region of the molecule
in conferring the speci¢city and e⁄ciency to the entire inhib-
itor molecule.
3.3. The e¡ect of phosphorylation on formation of the
calpain-calpastatin complex
The decrease in calpastatin inhibitory activity generated by
phosphorylation is also enhanced by the increase in the Ca2
concentration required for the formation of the calpain- in-
hibitor complex. This has been demonstrated by the following
experiment in which immobilized W-calpain was used to assay
the enzyme-inhibitor complex in the presence of increasing
[Ca2] and with dephosphorylated or phosphorylated calpa-
statin molecules. As shown in Fig. 4, unphosphorylated low
Mr calpastatin was not retained by the resin in the absence of
Ca2. In the presence of 5 WM Ca2, only a few molecules of
calpastatin were retained, whereas at 50 WM Ca2, all calpa-
statin molecules remained associated to the resin. Under the
same experimental conditions, the phosphorylated calpastatin
required a 10-fold higher concentration of Ca2 to be retained
by the resin through the formation of the complex with cal-
pain. Identical results were obtained using recombinant cal-
pastatin (data not shown).
Taken together, these results indicate that phosphorylation
modulates the inhibitory properties of calpastatin by changing
both the e⁄ciency and a⁄nity for calpain.
3.4. Phosphorylation of high Mr recombinant calpastatins
The rat brain contains mRNA encoding high Mr calpasta-
tin forms, di¡ering one from the other by the presence of
peptides deriving from speci¢c exones [6]. We have expressed
RNCAST104 and RNCAST107, containing four repetitive
domains together with the L-domain. The two calpastatin
forms were then analyzed for their susceptibility to phospho-
rylation by PKC. As shown in Fig. 5A, high Mr calpastatins
Fig. 2. The site of phosphorylation by PKC in recombinant and na-
tive low Mr calpastatin. Recombinant or native low Mr calpastatin
was incubated with PKC as described in the legend to Fig. 1 and in
Section 2. The reaction was stopped after 30 min of incubation,
when phosphorylation was completed, by heating at 90‡C for 3 min.
The sample was centrifuged at 50 000Ug for 10 min and the super-
natant, containing phosphocalpastatin, was collected. Phosphocal-
pastatin was recovered by a⁄nity chromatography on calpain-
Sepharose (Section 2.5) and then digested with trypsin (Section 2.6).
The tryptic peptides were separated by C-18 reverse phase chroma-
tography and the radioactive peptide, identi¢ed as described (Sec-
tion 2.6), was sequenced.
Fig. 3. The e¡ect of phosphorylation on the inhibitory e⁄ciency of
low Mr calpastatins. Rat brain-puri¢ed W-calpain (A, C) or m-cal-
pain (B, D) were incubated with the indicated amount of unphos-
phorylated (b) or phosphorylated (a) native or recombinant low
Mr calpastatin for 10 min at 37‡C in sodium borate bu¡er, pH 7.5,
containing 100 WM Ca2 or 1 mM Ca2 in the case of W-calpain or
m-calpain, respectively. The reaction was stopped by addition of tri-
chloroacetic acid (7.5% ¢nal concentration) and the samples were
centrifuged at 50 000Ug for 10 min. The calpastatin activity was as-
sayed in the supernatant using W-calpain and m-calpain puri¢ed
from rat brain. Data are expressed as percentage of the residual cal-
pain activity.
Fig. 4. The e¡ect of phosphorylation on the formation of the cal-
pain-calpastatin complex. Unphosphorylated (b) or phosphorylated
(a) native calpastatin was loaded on a calpain-Sepharose column
(see Section 2) in the presence of the indicated concentrations of
calcium. The retained inhibitor was eluted with the equilibrating
bu¡er containing 0.1 mM EDTA instead of calcium. The amount
of calpastatin retained by the immobilized calpain was determined
assaying the inhibitory activity eluted from the column.
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are phosphorylated by PKC at a lower extent as compared to
the low Mr forms (see Fig. 1). Only 0.5 equivalents of 32P
have been incorporated under the same conditions in which
phosphorylation of low Mr calpastatin was completed. Phos-
phorylation of both high Mr calpastatins results in a decrease
in their inhibitory e⁄ciency (Fig. 5B).
Furthermore, analysis of the tryptic peptides containing the
labelled phosphate groups has indicated also for the two high
Mr calpastatins that the phosphorylation catalyzed by PKC
occurs at the level of the same serine residue located within
the PKC target sequence near the N-terminal domain, as for
the low Mr calpastatin (data not shown).
4. Discussion
It is well-documented that calpastatin is the primary nega-
tive modulator of classical calpain forms [13^15]. However, it
has not yet completely been de¢ned (i) how calpain interacts
with calpastatin, (ii) how calpastatin can discriminate between
calpain isozymes and ¢nally, (iii) how calpain can escape the
calpastatin inhibition.
The ¢rst di⁄culty in providing ¢nal experimental responses
to these questions arises from the fact that both proteins,
enzyme and inhibitor, are localized in the same cell compart-
ment. This situation is rather unusual since normally the pro-
teinase inhibitors are localized in cell regions that must be
protected and not were the proteinases that are supposed to
be active. For instance, cystatins, the lysosomal proteinase
inhibitors, are preferentially cytosolic proteins and their tar-
gets, cathepsins, are con¢ned in lysosomes. This condition
does not apply to the calpain-calpastatin system in which
calpastatin is participating in the regulation of the calpain
activity in the same subcellular compartment. On the basis
of this assumption, however, selective mechanisms must be
operative in order to assure a continuous appropriate level
of active inhibitor and proteinase forms in order to provide
a controlled and selective degree of proteolysis.
The N-terminal region of calpastatin seems particularly rel-
evant for the overall function of the protein. This domain,
expressed by us as an isolated protein [8], although resulting
completely deprived of inhibitory activity, competes with the
other calpastatin forms and displaces the proteinase from the
complex with the inhibitory calpastatins. The role of this pro-
tein appears to be more relevant, since it contains also the site
of phosphorylation by PKC.
Phosphorylation of calpastatin results in a decrease in the
inhibitory e⁄ciency suggesting that phosphorylated calpasta-
tin can act as a reservoir of inhibitor molecules. The correla-
tion between the PKC-mediated signal transduction and cal-
pastatin phosphorylation remains to be elucidated, but it
suggests the existence of a pathway linking the calpain acti-
vation and regulation to external cell stimuli.
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Fig. 5. Phosphorylation of recombinant high Mr calpastatins by
PKC. (A) Recombinant RNCAST104 and RNCAST107 calpastatins
were incubated with PKC for the indicated times and in the condi-
tions described in Section 2 and in the legend of Fig. 1. The radio-
activity associated to RNCAST 104 (b) and to RNCAST107 (a) is
expressed as mol of 32P/mol of protein. (B) The inhibitory e⁄ciency
of RNCAST104 calpastatin (b) and RNCAST107 calpastatin (a),
unphosphorylated (solid lines) or phosphorylated (dotted lines),
were determined as reported in Section 2 and in the legend to Fig.
3, using rat brain W-calpain.
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